|
|
| Research article summary (published 15 Jun 2008): |
|
Free Full Text! See links below |
Pharmacologic mechanisms of crystal meth.
Full Abstract
Crystal meth is a form of the stimulant drug methamphetamine that, when smoked, can rapidly achieve high concentrations in the brain. Methamphetamine causes the release of the neurotransmitters dopamine, norepinephrine and serotonin and activates the cardiovascular and central nervous systems. The levels of dopamine are low in the brain of some drug users, but whether this represents neuronal loss is uncertain. The areas of the brain involved in methamphetamine addiction are unknown but probably include the dopamine-rich striatum and regions that interact with the striatum. There is no medication approved for the treatment of relapses of methamphetamine addiction; however, potential therapeutic agents targeted to dopamine and nondopamine (e.g., opioid) systems are in clinical testing.
Learn Faster Today Improve your study skills
Author information
Author/s: Kish, Stephen J (SJ);
Affiliation: Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Ont. stephen_kish(-atsign-)camh.net
Grants: 07186 (Agency:United States PHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (CMAJ), published in Canada. (Language: eng)
Reference: 2008-Jun; vol 178 (issue 13) : pp 1679-82
Dates: Created 2008/06/18; Completed 2008/07/03; Revised 2008/09/25;
PMID: 18559805, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentIn: CMAJ. 2008 Sep 9;179(6):558-9; author reply 559. (PMID: 18779530)
CommentIn: CMAJ. 2008 Sep 9;179(6):558; author reply 558. (PMID: 18779532)
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
30 Oct 2006 - Use of crystal methamphetamine among gay men in London.
30 Oct 2006 - Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use.
30 Jan 2008 - Community reactions to campaigns addressing crystal methamphetamine use among gay and bisexual men in New York City.
30 Dec 2005 - Mental health. Vancouver team uncovers self-medication with crystal meth.
30 Jul 2006 - Living with[out] crystal meth. Addicts were "those" people, not me.
29 Jun 2005 - Crystal meth use worsens HIV-related brain damage.
30 Mar 2005 - Living with crystal meth.
27 Feb 2005 - Crystal meth recovery. A step-by-step guide.
30 Aug 2005 - HIV and methamphetamines. Canadian group describes link between crystal meth and HIV.
17 May 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.